×
About 57,948 results

ALLMedicine™ Chronic Obstructive Pulmonary Disease Center

Research & Reviews  18,099 results

New ILD, asthma, and COPD trials
https://www.mdedge.com/chestphysician/article/256900/pulmonology/new-ild-asthma-and-copd-trials
Mark S. Lesney, PhD

Aug 9th, 2022 - This column presents a sampling of new and still-recruiting trials of interest to pulmonologists and their patients. Trials are selected based primarily on these conditions: idiopathic pulmonary fibrosis/interstitial lung disease; chronic obstruct.

Co-occurrence of pneumoconiosis with COPD, pneumonia and lung cancer.
https://doi.org/10.1093/occmed/kqac079
Occupational Medicine (Oxford, England); Rayens NT, Rayens EA et. al.

Aug 7th, 2022 - Pneumoconiosis is a well-documented occupational disease that is linked to conditions such as chronic obstructive pulmonary disease (COPD), pneumonia and congestive heart failure. Pneumoconiosis prevalence has decreased in the United States, but i...

Association between chronic obstructive pulmonary disease and periodontitis: The common...
https://doi.org/10.1016/j.cyto.2022.155982
Cytokine Ouyang Y, Liu J et. al.

Aug 7th, 2022 - Innate immune cells are of broad interest in a variety of diseases. These cells include neutrophils, macrophages, dendritic cells and mast cells, etc. Innate immune cells are often mentioned in inflammatory diseases as the first line of defense ag...

Trends, Predictors, and Outcomes of 30-Day Readmission With Heart Failure After Transca...
https://doi.org/10.1161/JAHA.121.024890
Journal of the American Heart Association; Zahid S, Din MTU et. al.

Aug 6th, 2022 - BACKGROUND Data on trends, predictors, and outcomes of heart failure (HF) readmissions after transcatheter aortic valve replacement (TAVR) remain limited. Moreover, the relationship between hospital TAVR discharge volume and HF readmission outcome...

Trends in all-cause mortality and inpatient and outpatient visits for ambulatory care s...
https://doi.org/10.1002/jhm.12920
Journal of Hospital Medicine; Kendzerska T, Zhu DT et. al.

Aug 6th, 2022 - The impact of the COVID-19 pandemic on the management of ambulatory care sensitive conditions (ACSCs) remains unknown. To compare observed and expected (projected based on previous years) trends in all-cause mortality and healthcare use for ACSCs ...

see more →

Guidelines  24 results

Here's What Happened to Asthma, COPD Admissions After a Big Polluter Shut Down
https://www.medpagetoday.com/meetingcoverage/ats/98781
MedPage Today; Gever J.

May 18th, 2022 - SAN FRANCISCO -- For neighborhoods near a major coking operation in Pittsburgh, its shutdown at the end of 2015 was followed by markedly lower rates of respiratory disease hospitalizations, researchers reported here. Inpatient admissions for ch...

Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force ...
https://doi.org/10.1001/jama.2022.5692
JAMA , Mangione CM et. al.

May 11th, 2022 - Chronic obstructive pulmonary disease (COPD) is an irreversible reduction of airflow in the lungs. Progression to severe disease can prevent participation in normal activities because of deterioration of lung function. In 2020 it was estimated tha...

Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice ...
https://doi.org/10.7326/M20-7355
Annals of Internal Medicine; Lee RA, Centor RM et. al.

Apr 6th, 2021 - Antimicrobial overuse is a major health care issue that contributes to antibiotic resistance. Such overuse includes unnecessarily long durations of antibiotic therapy in patients with common bacterial infections, such as acute bronchitis with chro...

Long-Term Mechanical Ventilation: Recommendations of the Swiss Society of Pulmonology.
https://doi.org/10.1159/000510086
Respiration; International Review of Thoracic Diseases; Janssens JP, Michel F et. al.

Dec 11th, 2020 - Long-term mechanical ventilation is a well-established treatment for chronic hypercapnic respiratory failure (CHRF). It is aimed at improving CHRF-related symptoms, health-related quality of life, survival, and decreasing hospital admissions. In S...

Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pul...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427384
American Journal of Respiratory and Critical Care Medicine; Macrea M, Oczkowski S et. al.

Aug 17th, 2020 - Background: Noninvasive ventilation (NIV) is used for patients with chronic obstructive pulmonary disease (COPD) and chronic hypercapnia. However, evidence for clinical efficacy and optimal management of therapy is limited.Target Audience: Patient...

see more →

Drugs  155 results see all →

Clinicaltrials.gov  2,857 results

A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
https://clinicaltrials.gov/ct2/show/NCT05037929

Aug 5th, 2022 - This study will evaluate the efficacy, safety, and pharmacokinetics of astegolimab in combination with standard of care chronic obstructive pulmonary disease (COPD) maintenance therapy in patients with COPD who are former or current smokers and ha...

Effects of Adding Yoga Respiratory Training to Osteopathic Manipulative Treatment in Pulmonary Arterial Hypertension
https://clinicaltrials.gov/ct2/show/NCT04076241

Aug 5th, 2022 - Pulmonary arterial hypertension (PAH) is characterized by a mean pulmonary arterial pressure of >20 mmHg, measured by right heart catheterization at rest. PAH begins in the small arteries of the pulmonary vasculature and is characterized by increa...

Role of Genetic Factors in the Development of Lung Disease
https://clinicaltrials.gov/ct2/show/NCT00001532

Aug 4th, 2022 - This study is designed to evaluate genetic mechanisms of lung disease by surveying polymorphic genes involved in respiratory function and examining gene expression in the lung cells of individuals with pulmonary disease (e.g., alpha 1-antitrypsin ...

Intervention to Reduce Misused Inhaler and Insufficient Peak Inspiratory Flow in Hospitalized COPD Patients
https://clinicaltrials.gov/ct2/show/NCT05207631

Aug 4th, 2022 - The drug treatment of chronic obstructive pulmonary disease (COPD) is mainly based on inhaled therapy. This route of administration is limited by inhaler handling errors, insufficient inspiratory flow or inappropriate inhalers. According to the sc...

HIIT Effects on Long-term Survival in Heart Failure Patients
https://clinicaltrials.gov/ct2/show/NCT05487716

Aug 4th, 2022 - METHODS Participants The institutional review board of a tertiary care hospital approved the retrospective cohort study protocol. Patients with cardiovascular events between 1 January 2009 and 31 May 2022 in a tertiary care hospital and the follow...

see more →

News  2,021 results

New ILD, asthma, and COPD trials
https://www.mdedge.com/chestphysician/article/256900/pulmonology/new-ild-asthma-and-copd-trials
Mark S. Lesney, PhD

Aug 9th, 2022 - This column presents a sampling of new and still-recruiting trials of interest to pulmonologists and their patients. Trials are selected based primarily on these conditions: idiopathic pulmonary fibrosis/interstitial lung disease; chronic obstruct.

Trials Data on COPD Leave Primary Care Docs in the Dark
https://www.medscape.com/viewarticle/978825

Aug 8th, 2022 - Primary care clinicians often struggle to care for their patients with chronic obstructive pulmonary disease (COPD), thanks to a lack of real-world evidence as to which treatments work best. As a result, potentially preventable life-threatening ex...

Exercise Limitations in COPD -- Not Everyone Needs More Inhalers
https://www.medscape.com/viewarticle/978128

Jul 29th, 2022 - Chronic obstructive pulmonary disease (COPD) is defined by airway obstruction and alveolar damage caused by exposure to noxious air particles. The physiologic results include varying degrees of gas-exchange abnormality and mechanical respiratory l...

Topical Roflumilast Approved for Psoriasis in Adults and Adolescents
https://www.medscape.com/viewarticle/978324

Jul 29th, 2022 - The US Food and Drug Administration (FDA) has approved roflumilast 0.3% cream for the topical treatment of plaque psoriasis, "including intertriginous areas," in patients aged 12 years and older. Roflumilast is a selective inhibitor of phosphodies...

Hypertension Heightens Risk for Severe COVID-19, Even in the Fully Vaxxed
https://www.medscape.com/viewarticle/978078

Jul 27th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Adults with hypertension who were vaccinated for COVID-19 with at least one booster were more than twice as likely as vaccinated and boosted indiv...

see more →

Patient Education  23 results see all →